jhfdsh3-sskm

Covid restrictions to be eased for travellers to Myanmar via int’l flights

The rules and regulations for COVID-19 will be relaxed for travellers to Myanmar via international flights starting from 1 December, according to the Ministry of Health.
The local infection rate has declined and the positivity rate has reached below one per cent for 14 consecutive days, it is learnt.
Before, the travellers were required to show COVID-19 vaccination record cards as proof of being fully vaccinated or the RT-PCR negative test results within 48 hours. And then they would have to take the RDT test at the airport.
Now, the restrictions to take tests with RDT will be relaxed for travellers to Myanmar starting from the morning of 1 December, according to the announcement of the Health Ministry.
The details will be published in “Public Health Requirements for Travellers who Wish to Enter Myanmar through International Commercial Flights” on 1 December.
In addition, the public health requirements for travellers by relief flights and travellers via land borders will remain the same as the requirements were released on 8 October 2022, it is learnt.

Source: Global New Light of Myanmar

bann-sskm

Covid-19 loan repayment period extended for one more year

The working committee to address the impact of Coronavirus Disease 2019 (COVID-19) on 4 November announced Notification 3/2022 on a one-year extension of the Covid loan repayment period from the second-year due date. According to the priority sector, 5,990 companies and enterprises were granted loans from K200 billion of COVID-19 funds for a total of K158.4438 billion with an interest rate of one per cent and a loan period of one year from 9 April 2020.

Loans flow to businesses such as CMP, hotels and tourism, small and medium-scale enterprises, agriculture, livestock breeding and marine production, export products manufacturing industries, import-substitute products manufacturing industries, businesses that participate in the supply chain from local production to the export sector, foodstuffs manufacturing businesses, overseas employment agencies and vocational training schools.

In the notice of the working committee for loans, it stated: “If it fails to repay, action will be taken under the law,” and so companies/industries that took loans from the Myanma Economic Bank fail to pay back the capital and interest, they will face legal action as per the terms and conditions of the loan contract and they must repay the outstanding loan completely within the period of extension. 

Source: The Global New Light of Myanmar

shutterstock1784722979

Republic of the Union of Myanmar
Announcement of Central Committee on
Prevention, Control and Treatment on
Coronavirus Disease 2019 (COVID-19)

7th Waxing of Tazaungmone 1384 ME
30 October 2022

As it is necessary to continuously control the infection of Coronavirus Disease 2019 (COVID-19),
it is hereby announced that public requests, orders, notifications and directives (except for
easing the restrictions) released by the Union-level organizations and Union ministries up to 31
October 2022 have been extended until 30 November 2022 for prevention, control and treatment
of Coronavirus Disease 2019 (COVID-19).

Source: The Global New Light of Myanmar

paxlovid-file-rt-jef-220310_1646954144162_hpMain_16x9_1600

Anti-Covid medicine successfully produced

Anti-Covid medicine will be produced when an order is received from the Ministry of Health, according to the Myanma Pharmaceutical Industry, Ministry of Industry.

Myanma Pharmaceutical Industry produces various kinds of medicines, including Covid vaccines, for the Ministry of Health and has been producing K55 billion worth of COVID vaccines since the outbreak of the pandemic. Paclovid (Nirmatrelvir 150 mg + Ritonavir 100 mg) is a kind of Covid drug.

A packet of Paclovid (30 capsules) costs K250,000 and is available only on prescription, according to Pacific Medical Industries. Pacific Medical Industries Ltd successfully produced the medicine with Myanmar FDA recommendation number (2308ND 012). The medicine is also recommended by WHO, US FDA, UK MHRA, Korean FDA, and Singapore FDA.

Source: The Global New Light of Myanmar

thumbs_b_c_562d6bee393393c657a0cf654fe104aa

Republic of the Union of Myanmar
Announcement of Central Committee on Prevention, Control and
Treatment on Coronavirus Disease 2019 (COVID-19)

5th Waxing of Thadingyut 1384 ME
29 September 2022

As it is necessary to continuously control the infection of Coronavirus Disease 2019 (COVID-19), it is hereby announced that public requests, orders, notifications and directives (except for easing the restrictions) released by the Union-level organizations and Union ministries up to 30 September 2022 have been extended until 31 October 2022 for prevention, control and treatment of Coronavirus Disease 2019 (COVID-19).

Source: The Global New Light of Myanmar

myanmar_Covid_1635702343668_1635702347995

Republic of the Union of Myanmar Announcement of Central Committee on Prevention, Control and Treatment of Coronavirus Disease 2019 (COVID-19)

5th Waxing of Tawthalin 1384 ME
30 August 2022

As it is necessary to continuously control infection of the Coronavirus Disease 2019 (COVID-19), it is hereby announced that public requests, orders, notifications and directives (except for easing the restrictions) released by the Union-level organizations and Union ministries up to 31 August 2022 have
been extended until 30 September 2022 for prevention, control and treatment of Coronavirus Disease 2019 (COVID-19).

Source: The Global New Light of Myanmar

download

Republic of the Union of Myanmar Announcement of Central Committee on Prevention, Control and Treatment of Coronavirus Disease 2019 (COVID-19)

3rd Waxing of Wagaung 1384 ME
30 July 2022

As it is necessary to continuously control infection of the Coronavirus Disease 2019 (COVID-19), it is hereby announced that public requests, orders, notifications and directives (except for easing the restrictions) released by the Union-level organizations and Union ministries up to 31 July 2022 have been extended until 31 August 2022 for prevention, control and treatment of Coronavirus Disease 2019 (COVID-19).

Source: The Global New Light of Myanmar

95560c944fae4fe494b6acb839e0da3b

China will play a constructive role in the interests of the people of Myanmar

MoI Union Minister U Maung Maung Ohn gives the speech at the opening ceremony of the training.
AMBASSADOR of the People’s Republic of China to Myanmar Chen Hai presented two million doses of
COVID-19 vaccines, which were donated to Myanmar, to Deputy Prime Minister and Minister for Foreign Affairs and International Cooperation of Cambodia, Special Envoy of the ASEAN Chair Mr Prak Sokhonn on 30 June at his residence. The ambassador made the remarks in an interview regarding the donation of the COVID-19 vaccine to Myanmar as follows: – Through efforts of the government and individuals from various fields, Myanmar’s COVID-19 disease prevention and control efforts have been successful and the COVID-19 disease prevention situation has been controlled domestically.

Myanmar is a neighbouring country and China has provided effective assistance to prevent and control the disease. China has provided more than 50 million COVID-19 vaccines to Myanmar, and two million more vaccines were successfully presented to the ASEAN Special Envoy to Myanmar. Last winter, the situation of COVID-19 cases became severe in Myanmar, and China provided Myanmar with relief supplies to China’s border areas and border crossings, as well as Oxygen cylinders and fluids, were helped to reach Myanmar as soon as possible. Not only the Chinese government but also Myanmar-based Chinese companies have donated to monasteries and charities during their project implementations. The Chinese government has sent medical experts to help prevent and control COVID-19 in Myanmar.

China and Myanmar are connected by mountains, and it is a mutually supportive community. China is proud of Myanmar’s success in COVID-19 disease prevention and control measures. China will continue to cooperate in disease prevention and control measures, taking the need for friends of Myanmar into account while there is little transparency in the global COVID-19 pandemic. The two countries are also stepping up cooperation in the prevention and control of the virus, and one of the important activities is the Sino-Myanmar joint venture between China and Myanmar to produce Chinese Sinopharm COVID-19 vaccines in Myanmar. It is seen that the vaccines produced in Myanmar are effective. In the ‘Myancopharm’ vaccine, Myan is Myanmar and co refers to COVID, and pharm is Sinopharm, which indicates the deepening of Sino-Myanmar cooperation.

The Chinese Embassy will co-operate in the joint production of the COVID-19 vaccine from start to finish, and the Ministry of Industry and the Ministry of Health are proud to see the results of the two countries’ cooperation in medicine. Experts in China are reviewing the Myanmar vaccine to improve the quality of the vaccine, which is still being vaccinated and is guaranteeing public health. We have also raised the standard of the pharmaceutical industry in Myanmar and would like to discuss other industrial cooperation issues from the joint venture with Myanmar friends. Through this, the living standards of the people will be improved and there will be benefits for economic rehabilitation. COVID-19 is a global catastrophe and is affecting both countries. Under the leadership of the Communist Party of China, China has adhered to the COVID-19 policy and is working to prevent and control the disease, ensuring China’s economic stability and development.

China is confident that it will successfully achieve the economic development goals set out in the beginning. China will work with Myanmar to prevent and control the disease and will do its utmost to help Myanmar’s economic recovery. We, the diplomats, live in Myanmar and share the common feelings of the people affected by COVID-19 disease. The disease cannot stop the bilateral cooperation, and China has been continuously cooperating in various fields by reviewing the needs of Myanmar people’s living and economic difficulties. As agriculture is a major factor in the country’s development, China is the largest importer of agricultural products and fishery products from Myanmar, and efforts are being made to facilitate cross-border trade in the control of COVID-19 disease in the border areas of the two countries. Due to insufficient power generation in Myanmar, we will continue to pay attention to cooperation in the electric power sector.

China wishes for the better development of its neighbour and strives for further cooperation between the two countries. The donated COVID-19 vaccine will be available in all parts of the country where needed, and one of China’s hopes is that all aid will be available to all Myanmar people. COVID-19 vaccines have also been provided in border areas of Myanmar bordering China’s Yunnan province, and efforts have been made to increase disease control. Now that Myanmar has been able to control the COVID-19 virus, it is one of the 10 least affected countries in ASEAN, according to a government release. We need to be aware of the risk of recurrence of the disease if we come in contact with the international community, and we will continue to cooperate in disease prevention activities while maintaining the control outcome. He said China would play a constructive role in the interests of the people of Myanmar and wished Myanmar peace.

Source: The Global New Light of Myanmar

covid-19-cases-rise-to-290

People to be vaccinated against COVID-19 at Yangon General Hospital every Wednesday

The Yangon General Hospital announced on 29 June that they will vaccinate the people against COVID-19 at the special outpatient department every Wednesday. The service hours will be from 9 am to 12 noon on Wednesday.

They will vaccinate the people over the age of 18 against COVID-19 and booster shots for the people over 40 who received second shots six months ago. Officials arrange an online booking system for the vaccination programme.

The government used the Indian-made Covishield, China-made Sinopharm and Sinovac and Russia’s Sputnik light starting in January 2021. Myanmar has vaccinated over 29.84 million people over 18 and 5.35 million people under 18 against COVID-19 as of 25 June, according to the Ministry of Health.

Source: The Global New Light of Myanmar

604256

Republic of the Union of Myanmar Announcement of Central Committee on Prevention, Control and Treatment of Coronavirus Disease 2019 (COVID-19)

2nd Waxing of Waso 1384 ME
29 June 2022

As it is necessary to continuously control infection of the Coronavirus Disease 2019 (COVID-19),
it is hereby announced that public requests, orders, notifications and directives (except for easing
the restrictions) released by the Union-level organizations and Union ministries up to 30 June
2022 have been extended until 31 July 2022 for prevention, control and treatment of Coronavirus
Disease 2019 (COVID-19).

Source: The Global New Light of Myanmar